Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
Clinical trial NCT05501899 · RECRUITING
Trial details
- NCT number
- NCT05501899
- Sponsor
- Children's Hospital of Orange County
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-03
- Primary completion
- 2024-12-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.